Feeney John Joseph 4
4 · Vanda Pharmaceuticals Inc. · Filed Feb 19, 2010
Insider Transaction Report
Form 4
Feeney John Joseph
Acting Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2010-02-18+20,000→ 20,000 total - Exercise/Conversion
Restricted Stock Units
2010-02-18−20,000→ 0 total→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units represented a contingent right to receive a share of the Issuer's common stock which vested on December 31, 2009.
- [F2]N/A